Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination
- PMID: 9291157
- DOI: 10.1177/135245859700300203
Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination
Abstract
Studies in both humans and experimental animals indicate that there is potential for full remyelination following CNS demyelination, but the factors that control the degree of myelin repair are unknown. In the Theiler's virus model of demyelination CNS remyelination can be promoted either by global immunosuppression or by selective immunoglobulin therapy. In this paper we discuss whether immunoglobulin-mediated remyelination is a characteristic of immune-mediated demyelination, or whether immunoglobulin-mediated remyelination also occurs in the toxic-traumatic model of lysolecithin-induced demyelination. Our data support the hypothesis that even in a non-primary immune model of demyelination, manipulating the immune system can be beneficial in myelin repair.
Similar articles
-
Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis.J Neurol Neurosurg Psychiatry. 1994 Nov;57 Suppl(Suppl):65-8. doi: 10.1136/jnnp.57.suppl.65. J Neurol Neurosurg Psychiatry. 1994. PMID: 7964859 Free PMC article. Review.
-
Spontaneous and induced remyelination in multiple sclerosis and the Theiler's virus model of central nervous system demyelination.Microsc Res Tech. 1995 Oct 15;32(3):230-45. doi: 10.1002/jemt.1070320306. Microsc Res Tech. 1995. PMID: 8527857 Review.
-
Immune promotion of central nervous system remyelination.Prog Brain Res. 1994;103:343-55. doi: 10.1016/s0079-6123(08)61148-6. Prog Brain Res. 1994. PMID: 7886217 Review.
-
Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination.J Neurosci. 1998 Apr 1;18(7):2498-505. doi: 10.1523/JNEUROSCI.18-07-02498.1998. J Neurosci. 1998. PMID: 9502810 Free PMC article.
-
Immunoglobulins promote remyelination in the central nervous system.Ann Neurol. 1990 Jan;27(1):12-7. doi: 10.1002/ana.410270104. Ann Neurol. 1990. PMID: 2301922
Cited by
-
Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis.J Clin Invest. 2006 Apr;116(4):905-15. doi: 10.1172/JCI26836. Epub 2006 Mar 23. J Clin Invest. 2006. PMID: 16557302 Free PMC article.
-
Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications.Med Sci (Basel). 2017 Oct 13;5(4):23. doi: 10.3390/medsci5040023. Med Sci (Basel). 2017. PMID: 29099039 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources